Encore: Diet Wars | Dieting 3.0 | 5

The AI revolution is here and the tech behemoths are building and releasing their own chatbots. To talk about their victories and blunders, we're joined by Vox journalist Shirin Ghaffary and comedian and podcast host Jolenta Greenberg.Binge all episodes early and ad-free with Won ...  Show more

While the U.S. government pushed automakers to make low-emission vehicles in the 1990s, consumers loved their gas-guzzling trucks and SUVs. But in 2003, Elon Musk's Tesla Motors arrives with environmentally friendly, high-performance cars that people actually want.Motor City smir ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

The latest fad diet isn’t a diet, it’s a shot — Ozempic is being called a miracle weight loss drug, and it’s disrupting Weight Watchers. LVMH is proud of their pricey perfume, and they are selling more than ever thanks to their Rihanna-aided storytelling. And H&R Block vs. TurboT ...  Show more

Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more